Market Highlights
Drug screening is the process of collecting, identifying, and analysing biological samples such as blood, urine, hair, or saliva to detect the presence of chemicals and contaminants left behind in the body due to drug use. It may also be used to detect performance-enhancing drugs in the body, sometimes used by professional athletes such as steroids and HGH. Drug screening tests are used to determine whether a person is or was under the influence of drugs at a certain point of time.
The COVID-19 pandemic had a significant impact on businesses and economic activities around the world, as well as a short-term negative impact on the drug screening market. Lockdowns and social distancing restrictions across the world, limited medical facilities, supply chain disruption, postponement of non-essential medical services were the factors which affected the growth of the drug screening market in the year 2020. In addition, the trade barriers and the demand-supply gap also impacted the drug screening market in 2020.
However, the overall drug screening market is estimated to grow at a decent CAGR of 15% during the forecast period to reach a value of US$ 12 Billion in 2027. Major factors such as growing drug and alcohol consumption, stringent government regulations mandating drug and alcohol testing, and rising regulatory approvals for drug screening products and services are expected to drive the market growth during the forecast period. Furthermore, the increasing prevalence of substance abuse around the world, growing number of road accidents caused by drug overdoses, and prescription drug misuse are the other major factors likely to drive the growth of the drug screening market over the forecast period. Furthermore, the market is expected to be driven by the development of advanced screening devices and increasing awareness about the benefits of drug screening in workplaces and schools.
Key Players
The following are some of the key players in the drug screening market:
- Abbott Laboratories
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Clinical Reference Laboratory, Inc.
- Laboratory Corporation of America Holdings (Labcorp)
- Legacy Medical Services, LLC.
- Omega Laboratories, Inc.
- Quest Diagnostics Incorporated
- Quidel Corporation
- Thermo Fisher Scientific, Inc.
Market Segments' Analysis
Based on the product and service type, the market is bifurcated into equipment, rapid testing devices, consumables, and laboratory services. Equipment is further sub-segmented into immunoassay analyzers, chromatography instruments, and breath analyzers. The rapid testing devices segment is further sub-segmented into urine testing devices and oral fluid testing devices. The consumables segment is further sub-segmented into assay kits, sample collection cups, calibrators and controls, and others. The rapid testing devices segment is expected to grow with the highest CAGR during the forecast period due to higher health awareness amongst people, post the COVID-19 pandemic. In addition, the high growth in this segment is owing to the advantages it offers such as shorter detection window, non-invasive nature, and low risk of sample tampering.
Based on the sample type, the market is segmented as urine samples, breath samples, oral fluid samples, hair samples, and others. Urine samples dominated the market and accounted for the major share of the market in 2021, and are expected to grow with the highest CAGR during the forecast period as they are the most commonly used sample types to detect the presence of illicit substances.
Based on the end-user type, the market is segmented as drug testing laboratories, workplaces and schools, criminal justice systems & law enforcement agencies, hospitals, drug treatment centers, individual users, and pain management centers. Among these end-user types, drug testing laboratories held the major share of the market in 2021, and are expected to witness the highest growth during the forecast period. The availability of sophisticated equipment and trained personnel for conducting tests for effective results is the major factor likely to fuel the segment's growth over the forecast period.
In terms of regions, North America is the largest region in the market for drug screening. Growing consumption of illicit drugs, government regulations and funding to combat drug abuse, laws supporting drug screening, an increase in the number of accidents, and the presence of key players in the region are all driving the growth of the drug screening market in North America. Furthermore, favourable reimbursement scenarios and the adoption of highly technologically advanced solutions in the region are expected to drive the market growth over the forecast period.
The drug screening market is segmented into the following categories:
Drug Screening Market, by Product and Service Type
- Equipment
- Regional Analysis: North America, Europe, Asia-Pacific, and Rest of the World
- Type Analysis: Immunoassay Analyzers, Chromatography Instruments, and Breath Analyzers
- Rapid Testing Devices
- Regional Analysis: North America, Europe, Asia-Pacific, and Rest of the World
- Type Analysis: Urine Testing Devices and Oral Fluid Testing Devices
- Consumables
- Regional Analysis: North America, Europe, Asia-Pacific, and Rest of the World
- Type Analysis: Assay Kits, Sample Collection Cups, Calibrators and Controls, and Others
- Laboratory Services (Regional Analysis: North America, Europe, Asia-Pacific, and Rest of the World)
Drug Screening Market, by Sample Type
- Urine Samples (Regional Analysis: North America, Europe, Asia-Pacific, and Rest of the World)
- Breath Samples (Regional Analysis: North America, Europe, Asia-Pacific, and Rest of the World)
- Oral Fluid Samples (Regional Analysis: North America, Europe, Asia-Pacific, and Rest of the World)
- Hair Samples (Regional Analysis: North America, Europe, Asia-Pacific, and Rest of the World)
- Others (Regional Analysis: North America, Europe, Asia-Pacific, and Rest of the World)
Drug Screening Market, by End-User Type
- Drug Testing Laboratories (Regional Analysis: North America, Europe, Asia-Pacific, and Rest of the World)
- Workplaces and Schools (Regional Analysis: North America, Europe, Asia-Pacific, and Rest of the World)
- Criminal Justice Systems & Law Enforcement Agencies (Regional Analysis: North America, Europe, Asia-Pacific, and Rest of the World)
- Hospitals (Regional Analysis: North America, Europe, Asia-Pacific, and Rest of the World)
- Drug Treatment Centers (Regional Analysis: North America, Europe, Asia-Pacific, and Rest of the World)
- Individual Users (Regional Analysis: North America, Europe, Asia-Pacific, and Rest of the World)
- Pain Management Centers (Regional Analysis: North America, Europe, Asia-Pacific, and Rest of the World)
Drug Screening Market, by Region
- North America (Country Analysis: The USA, Canada, and Mexico)
- Europe (Country Analysis: Germany, France, The UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and Rest of Asia-Pacific)
- Rest of the World (Country Analysis: Brazil, Argentina, and Others)
Research Methodology
This strategic assessment report, from Stratview Research, provides a comprehensive analysis that reflects today’s drug screening market realities and future market possibilities for the forecast period of 2022 to 2027. The report segments and analyzes the market in the most detailed manner in order to provide a panoramic view of the market. The vital data/information provided in the report can play a crucial role for the market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate the growth strategies to expedite their growth process.
This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.
Report Features
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
- Market structure: Overview, industry life cycle analysis, supply chain analysis.
- Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis.
- Market trend and forecast analysis.
- Market segment trend and forecast.
- Competitive landscape and dynamics: Market share, Product portfolio, New Product Launches, etc.
- Attractive market segments and associated growth opportunities.
- Emerging trends.
- Strategic growth opportunities for the existing and new players.
- Key success factors.
Report Customization Options
With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:
Company Profiling
- Detailed profiling of additional market players (up to three players)
- SWOT analysis of key players (up to three players)
Competitive Benchmarking
- Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances
Custom Research: Stratview research offers custom research services across the sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected]